Market Overview

Amazon To Buy Online Pharmacy PillPack; Drug Store Stocks Fall

Share:
Amazon To Buy Online Pharmacy PillPack; Drug Store Stocks Fall
Related AMZN
Tigress Financial's Feinseth Says Amazon Is Winning The Connective Battle
From Facebook To Netflix: The S&P's Big Sector Shakeup, Explained
Facebook: What Now? (Seeking Alpha)

The pharmaceutical industry needs an ice pack.

Amazon.com, Inc. (NASDAQ: AMZN) struck a blow Thursday with its acquisition of PillPack, an online pharmacy.

"PillPack's visionary team has a combination of deep pharmacy experience and a focus on technology," Jeff Wilke, Amazon CEO Worldwide Consumer, said in a press release. "PillPack is meaningfully improving its customers' lives, and we want to help them continue making it easy for people to save time, simplify their lives, and feel healthier.”

Why It’s Important

Armed with PillPack, which fulfills prescriptions online and delivers medications to consumer homes, Amazon becomes a competitive threat to retail pharmacies.

CVS Health Corp (NYSE: CVS) fell 6 percent, Rite Aid Corporation (NYSE: RAD) 10.6 percent and Walgreens Boots Alliance Inc (NASDAQ: WBA) 9.9 percent on the news. Express Scripts Holding Co (NASDAQ: ESRX) also dropped 1.4 percent, and Walmart Inc (NYSE: WMT), which expressed interest in PillPack earlier this year, fell 1.2 percent.

"Together with Amazon, we are eager to continue working with partners across the healthcare industry to help people throughout the U.S. who can benefit from a better pharmacy experience," TJ Parker, co-founder and CEO of PillPack, said in the release.

Not The First Time

It’s worth noting, though, that a step of this nature wasn't unexpected. Amazon has been building momentum behind health care pursuits for some time.

Earlier this year, Loup Ventures noted the firm was well positioned to disrupt the pharmacy benefit management industry, patient-provider interactions and patient data networks.

In January, Amazon teamed up with JPMorgan Chase & Co. (NYSE: JPM) and Berkshire Hathaway Inc. (NYSE: BRK-A) (NYSE: BRK-B) to disrupt the health care sector, and just last week, they appointed Dr. Atul Gawande the venture’s CEO.

In May 2017, the company reportedly hired a business manager to help break into the pharmacy market, and some expected the firm was building an internal pharmacy benefit manager for employees.

Before that, Amazon had begun selling medical supplies and equipment in the U.S. and specific substances globally. In Japan, it collaborated with pharmacies on prescription drug delivery.

What’s Next

The transaction is expected to close in the second half of 2018. How Amazon will integrate the program into its Prime membership program is yet to be seen.

Related Links:

Amazon's Pharma Aspirations: Cowen Finds No New License Applications

Analyst: Why Diplomat Could Be Amazon's Ticket Into The Pharma Space

Posted-In: Jeff Wilke PillPackNews Health Care M&A Top Stories General Best of Benzinga

 

Related Articles (AMZN + BRK-A)

View Comments and Join the Discussion!

The Market In 5 Minutes: Anthony Kennedy, Chipotle, 'Raw,' Smackdown' And More

Benzinga's Daily Biotech Pulse: Eli Lilly, Edge Therapeutics, BioXcel Report Positive Trial Results, 4 Stocks Debut